Volume 76, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645


Few studies have documented the effectiveness in west Africa of intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine (SP) in pregnancy. Pregnant Nigerian women were assigned to receive either SP given twice or presumptive chloroquine (CQ) treatment followed by weekly pyrimethamine (CQ + P); 250 were enrolled in each group. Of those completing follow-up, 4 (1.8%) in the SP group and 22 (9.8%) in the CQ + P groups had a febrile illness ( = 0.005). None in the SP group but 11 (4.9%) in the CQ + P group had peripheral parasitemia prior to or during delivery ( = 0.002). Two (1.2%) in the SP group and 9 (5.0%) in the CQ + P group were anemic at delivery ( = 0.04). There were six low birth weight infants in the SP group and eight in the CQ + P group ( = 0.21). Intermittent preventive treatment with SP is superior to CQ + P for prevention of malaria and anemia in pregnant women in Nigeria.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Diagne N, Rogier C, Sokhna CS, Tall A, Fontenille D, Roussilhon C, Spiegel A, Trape JF, 2000. Increased susceptibility to malaria during the early postpartum period. N Engl J Med 343 : 598–603. [Google Scholar]
  2. Anya SE, 2004. Seasonal variation in the risk and causes of maternal death in The Gambia: malaria appears to be an important factor. Am J Trop Med Hyg 70 : 510–513. [Google Scholar]
  3. van Geertruyden JP, Thomas F, Erhart A, D’Alessandro U, 2004. The contribution of malaria in pregnancy to perinatal mortality. Am J Trop Med Hyg 71 : 35–40. [Google Scholar]
  4. Tako EA, Zhou A, Lohoue J, Leke R, Taylor DW, Leke RF, 2005. Risk factors for placental malaria and its effect on pregnancy outcome in Yaounde, Cameroon. Am J Trop Med Hyg 72 : 236–242. [Google Scholar]
  5. 2004. National Guidelines and Strategies for Malaria Prevention and Control during Pregnancy. Lagos: Federal Ministry of Health, Nigeria, 31.
  6. Steketee RW, Wirima JJ, Campbell CC, 1996. Developing effective strategies for malaria prevention programs for pregnant African women. Am J Trop Med Hyg 55 : 95–100. [Google Scholar]
  7. Schultz LJ, Steketee RW, Macheso A, Kazembe P, Chitsulo L, Wirima JJ, 1994. The efficacy of antimalarial regimens containing sulfadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum infection among pregnant women in Malawi. Am J Trop Med Hyg 51 : 515–522. [Google Scholar]
  8. Shulman CE, Dorman EK, Cutts F, Kawuondo K, Bulmer JN, Peshu N, Marsh K, 1999. Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial. Lancet 353 : 632–636. [Google Scholar]
  9. Verhoeff FH, Brabin BJ, Chimsuku L, Kazembe P, Russell WB, Broadhead RL, 1998. An evaluation of the effects of intermittent sulfadoxine-pyrimethamine treatment in pregnancy on parasite clearance and risk of low birthweight in rural Malawi. Ann Trop Med Parasitol 92 : 141–150. [Google Scholar]
  10. Newman RD, Moran AC, Kayentao K, Benga-De E, Yameogo M, Gaye O, Faye O, Lo Y, Moreira PM, Doumbo O, Parise ME, Steketee RW, 2006. Prevention of malaria during pregnancy in west Africa: policy change and the power of subregional action. Trop Med Int Health 11 : 462–469. [Google Scholar]
  11. Parise ME, Ayisi JG, Nahlen BL, Schultz LJ, Roberts JM, Misore A, Muga R, Oloo AJ, Steketee RW, 1998. Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. Am J Trop Med Hyg 59 : 813–822. [Google Scholar]
  12. Steketee RW, Wirima JJ, Bloland PB, Chilima B, Mermin JH, Chitsulo L, Breman JG, 1996. Impairment of a pregnant woman’s acquired ability to limit Plasmodium falciparum by infection with human immunodeficiency virus type-1. Am J Trop Med Hyg 55 : 42–49. [Google Scholar]
  13. Mount AM, Mwapasa V, Elliott SR, Beeson JG, Tadesse E, Lema VM, Molyneux ME, Meshnick SR, Rogerson SJ, 2004. Impairment of humoral immunity to Plasmodium falciparum malaria in pregnancy by HIV infection. Lancet 363 : 1860–1867. [Google Scholar]
  14. Ayisi JG, van Eijk AM, Newman RD, ter Kuile FO, Shi YP, Yang C, Kolczak MS, Otieno JA, Misore AO, Kager PA, Lal RB, Steketee RW, Nahlen BL, 2004. Maternal malaria and perinatal HIV transmission, western Kenya. Emerg Infect Dis 10 : 643–652. [Google Scholar]
  15. Sowunmi A, Fateye BA, 2003. Asymptomatic, recrudescent, chloroquine-resistant Plasmodium falciparum infections in Nigerian children: clinical and parasitological characteristics and implications for the transmission of drug-resistant parasites. Ann Trop Med Parasitol 97 : 469–479. [Google Scholar]
  16. Olumese PE, Amodu OK, Bjorkman A, Adeyemo AA, Gbadegesin RA, Walker O, 2002. Chloroquine resistance of Plasmodium falciparum is associated with severity of disease in Nigerian children. Trans R Soc Trop Med Hyg 96 : 418–420. [Google Scholar]
  17. Ogunbode O, Adewuyi J, Okwerekwu F, Awarun JA, 1991. Chemoprophylaxis during pregnancy in malaria endemic areas: practical considerations. Trop J Obstet Gynaecol 9 : 31–34. [Google Scholar]
  18. Nyirjesy P, Kavasya T, Axelrod P, Fischer PR, 1993. Malaria during pregnancy: neonatal morbidity and mortality and the efficacy of chloroquine chemoprophylaxis. Clin Infect Dis 16 : 127–132. [Google Scholar]
  19. Laxminarayan R, Mills AJ, Breman JG, Measham AR, Alleyne G, Claeson M, Jha P, Musgrove P, Chow J, Shahid-Salles S, Jamison DT, 2006. Advancement of global health: key messages from the Disease Control Priorities Project. Lancet 367 : 1193–1208. [Google Scholar]
  20. Nahlen BL, Akintunde A, Alakija T, Nguyen-Dinh P, Ogunbode O, Edungbola LD, Adetoro O, Breman JG, 1989. Lack of efficacy of pyrimethamine prophylaxis in pregnant Nigerian women. Lancet 2 : 830–834. [Google Scholar]
  21. Kayentao K, Kodio M, Newman RD, Maiga H, Doumtabe D, Ongoiba A, Coulibaly D, Keita AS, Maiga B, Mungai M, Parise ME, Doumbo O, 2005. Comparison of intermittent preventive treatment with chemoprophylaxis for the prevention of malaria during pregnancy in Mali. J Infect Dis 191 : 109–116. [Google Scholar]
  22. Sirima SB, Cotte AH, Konate A, Moran AC, Asamoa K, Bougouma EC, Diarra A, Ouedraogo A, Parise ME, Newman RD, 2006. Malaria prevention during pregnancy: assessing the disease burden one year after implementing a program of intermittent preventive treatment in Koupela District, Burkina Faso. Am J Trop Med Hyg 75 : 205–211. [Google Scholar]
  23. Sirima SB, Sawadogo R, Moran AC, Konate A, Diarra A, Yameogo M, Parise ME, Newman RD, 2003. Failure of a chloroquine chemoprophylaxis program to adequately prevent malaria during pregnancy in Koupela District, Burkina Faso. Clin Infect Dis 36 : 1374–1382. [Google Scholar]
  24. Mbaye A, Richardson K, Balajo B, Dunyo S, Shulman C, Milligan P, Greenwood B, Walraven G, 2006. A randomized, placebo-controlled trial of intermittent preventive treatment with sulphadoxine-pyrimethamine in Gambian multigravidae. Trop Med Int Health 11 : 992–1002. [Google Scholar]
  25. Coulibaly SO, Nezien D, Traore S, Kone B, 2006. Therapeutic efficacy of sulphadoxine-pyrimethamine and chloroquine for the treatment of uncomplicated malaria in pregnancy in Burkina Faso. Malar J 5 : 49. [Google Scholar]
  26. Pitmang SL, Thacher TD, Madaki JK, Egah DZ, Fischer PR, 2005. Comparison of sulfadoxine-pyrimethamine with and without chloroquine for uncomplicated malaria in Nigeria. Am J Trop Med Hyg 72 : 263–266. [Google Scholar]

Data & Media loading...

  • Received : 28 Aug 2006
  • Accepted : 18 Oct 2006

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error